Your browser doesn't support javascript.
loading
Functional analysis of a chromosomal deletion associated with myelodysplastic syndromes using isogenic human induced pluripotent stem cells.
Kotini, Andriana G; Chang, Chan-Jung; Boussaad, Ibrahim; Delrow, Jeffrey J; Dolezal, Emily K; Nagulapally, Abhinav B; Perna, Fabiana; Fishbein, Gregory A; Klimek, Virginia M; Hawkins, R David; Huangfu, Danwei; Murry, Charles E; Graubert, Timothy; Nimer, Stephen D; Papapetrou, Eirini P.
Affiliation
  • Kotini AG; 1] Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA. [2] The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA. [3] The Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, New
  • Chang CJ; 1] Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA. [2] The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA. [3] The Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, New
  • Boussaad I; 1] Division of Hematology, Department of Medicine, University of Washington, Seattle, Washington, USA. [2] Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, Washington, USA.
  • Delrow JJ; Genomics Resource, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Dolezal EK; Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, Florida, USA.
  • Nagulapally AB; 1] Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, Washington, USA. [2] Division of Medical Genetics, Department of Medicine, University of Washington, Seattle, Washington, USA.
  • Perna F; Molecular Pharmacology and Chemistry Program, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
  • Fishbein GA; 1] Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, Washington, USA. [2] Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
  • Klimek VM; Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
  • Hawkins RD; 1] Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, Washington, USA. [2] Division of Medical Genetics, Department of Medicine, University of Washington, Seattle, Washington, USA.
  • Huangfu D; Developmental Biology Program, Sloan-Kettering Institute, New York, New York, USA.
  • Murry CE; 1] Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, Washington, USA. [2] Department of Pathology, University of Washington, Seattle, Washington, USA. [3] Center for Cardiovascular Biology, University of Washington, Seattle, Washington, USA. [4] Department of Bioe
  • Graubert T; MGH Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Nimer SD; Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, Florida, USA.
  • Papapetrou EP; 1] Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA. [2] The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA. [3] The Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, New
Nat Biotechnol ; 33(6): 646-55, 2015 Jun.
Article in En | MEDLINE | ID: mdl-25798938
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myelodysplastic Syndromes / Genetic Engineering / Chromosome Deletion / Induced Pluripotent Stem Cells Type of study: Risk_factors_studies Limits: Animals / Humans Language: En Journal: Nat Biotechnol Journal subject: BIOTECNOLOGIA Year: 2015 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myelodysplastic Syndromes / Genetic Engineering / Chromosome Deletion / Induced Pluripotent Stem Cells Type of study: Risk_factors_studies Limits: Animals / Humans Language: En Journal: Nat Biotechnol Journal subject: BIOTECNOLOGIA Year: 2015 Document type: Article